ZYUS Life Sciences (CVE:ZYU) Earns “Speculative Buy” Rating from Stifel Canada

Stifel Canada reiterated their speculative buy rating on shares of ZYUS Life Sciences (CVE:ZYU – Free Report) in a report released on Friday, PriceTargets.com reports. ZYUS Life Sciences Stock Performance Read More Five stocks we like better than ZYUS Life Sciences Transportation Stocks Investing 3 semiconductor stocks to rally on latest U.S. grants Election Stocks: […]

Leave a Reply

Your email address will not be published.

Previous post Childress Capital Advisors LLC Makes New Investment in Alphabet Inc. (NASDAQ:GOOG)
Next post Toyota Retains World’s Top-Selling Automaker Crown as Chairman Apologizes over Scandals